Drug Trial Radar · NCT02413268
Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial
Last checked: Nov 19, 2026Latest source record: Sep 17, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,400
Planned (sponsor's estimate)
Start
Mar 2016
Primary completion
Jul 2020
Study completion Jul 2020
Sponsor
- Lead sponsor
- Total Cardiovascular SolutionsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 9, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized comparison of topical nitroglycerin versus placebo gel for prevention of radial artery occlusion after transradial catheterization.
Conditions
- Total Atherosclerotic Occlusion of Radial Artery
Interventions
NitroglycerinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Radial Artery OcclusionTime frame: up to 2 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Apex Heart Institute
Ahmedabad, Gujarat, India · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.